We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Anatomically Precise Ultrasound-Based Technique to Enable Noninvasive Biopsies for Brain Tumors

By MedImaging International staff writers
Posted on 28 Sep 2023
Print article
Image: The new device targets ultrasound waves to precise spots in the brain (Photo courtesy of WUSTL)
Image: The new device targets ultrasound waves to precise spots in the brain (Photo courtesy of WUSTL)

The blood-brain barrier serves as a protective wall, keeping the brain safe from harmful elements like viruses and toxins in the blood. This makes it challenging for doctors to obtain molecular and genetic information, which could be critical for diagnosing and treating brain conditions like cancer. Typically, neurosurgeons have to perform risky surgical biopsies to gather this data, which is not an option for every type of brain disease or tumor. Now, researchers have developed a method called sonobiopsy, which uses ultrasound technology and microbubbles to temporarily disrupt this barrier, allowing vital molecules like RNA, DNA, and proteins to move into the bloodstream where they can be detected and studied.

Researchers at Washington University in St. Louis (WUSTL, St. Louis, MO, USA) who had developed and previously tested the technique in animals have now demonstrated the technique to be feasible and safe for use in humans, paving the way for noninvasive biopsies for suspected brain tumors and other brain diseases. The researchers had to rely on an expensive ultrasound setup that had to be integrated with an MRI scanner, limiting its usage to specific locations. To make the procedure more accessible, the team designed a portable handheld ultrasound probe which was attached to a stereotactic pointer that is commonly used by neurosurgeons for identifying brain lesions. This new device could be seamlessly incorporated into existing medical procedures without the need for extra training for the neurosurgeons involved.

The sonobiopsy technique involves focusing ultrasound on a particular brain lesion with millimeter-scale accuracy, followed by injecting microbubbles into the bloodstream. These microbubbles reach the targeted area and burst, creating small, temporary openings in the blood-brain barrier. These openings seal themselves within a few hours, causing no lasting harm. This brief window allows biomolecules from the lesion to escape into the blood, making it possible to collect them through a standard blood test. The researchers applied this method to five individuals with brain tumors, later surgically removing the tumors as per standard medical protocols. Blood analysis conducted before and after the sonobiopsy showed a significant increase in circulating tumor DNA levels—anywhere from 1.6 to 5.6 times, based on the specific type of DNA being analyzed. This DNA offers critical insights into the genetic makeup of the tumor, influencing how aggressively it should be treated. Additionally, there was no evidence of brain tissue damage, affirming the safety of the procedure.

“Magnetic resonance imaging (MRI) revolutionized the field of brain disease diagnosis in the 1980s and ‘90s by allowing for structural and functional imaging of the brain,” said Eric C. Leuthardt, MD, co-inventor of the technology. “Sonobiopsy is the third revolution, the molecular revolution. With this technique, we can obtain a blood sample that reflects the gene expression and the molecular features at the site of a lesion in the brain. It’s like doing a brain biopsy without the dangers of brain surgery.”

“We’ve essentially initiated a new field of study for brain conditions,” added Hong Chen, the co-inventor of the technology. “With this capability to noninvasively, nondestructively access every part of the brain, we can get genetic information on tumors before going in surgically, which would help a neurosurgeon determine how best to approach the surgery. If they see something suspicious on imaging, they could confirm whether a tumor is recurring or not. We can now start to interrogate diseases for which surgical biopsies aren’t done, such as neurodevelopmental, neurodegenerative and psychiatric disorders.”

Related Links:

Gold Supplier
Ultrasound System
Gold Supplier
Conductive Gel
Ultrasonic Diagnostic System
Forensic Imaging System

Print article



view channel
Image: Intelligent NR provides high-quality diagnostic images containing significantly less grainy noise (Photo courtesy of Canon)

AI-Driven DR System Produces Higher Quality Images While Limiting Radiation Doses in Pediatric Patients

Ionizing radiation is a fundamental element in producing diagnostic X-rays, yet it's widely acknowledged for its cancer risk potential. Digital projection radiography, a vital imaging modality, accounts... Read more


view channel
Image: The researchers are using MRI-guided radiation therapy that pairs daily MRIs with radiation treatment (Photo courtesy of Sylvester)

AI Technique Automatically Traces Tumors in Large MRI Datasets to Guide Real-time Glioblastoma Treatment

Treating glioblastoma, a prevalent and aggressive brain cancer, involves the use of radiation therapy guided by CT imaging. While this method is effective in targeting radiation, it doesn't provide real-time... Read more

Nuclear Medicine

view channel
Image: A novel PET radiotracer facilitates early, noninvasive detection of IBD (Photo courtesy of Karmanos)

New PET Radiotracer Aids Early, Noninvasive Detection of Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is an inflammatory condition of the gastrointestinal tract affecting roughly seven million individuals globally.... Read more

General/Advanced Imaging

view channel
Image: Artificial intelligence predicts therapy responses for ovarian cancer (Photo courtesy of 123RF)

AI Model Combines Blood Test and CT Scan Analysis to Predict Therapy Responses in Ovarian Cancer Patients

Ovarian cancer annually impacts thousands of women, with many diagnoses occurring at advanced stages due to subtle early symptoms. High-grade serous ovarian carcinoma, which accounts for 70-80% of ovarian... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Attendees can discover innovative products and technology in the RSNA 2023 Technical Exhibits (Photo courtesy of RSNA)

RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More

The 109th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA, Oak Brook, IL, USA) to be held in Chicago, Nov. 26 to 30 is all set to offer a vast array of medical... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.